Get the Stockscreener App
94.34
0.38%
0.36
After Hours:
94.34
Vaxcyte Inc stock is traded at $94.34, with a volume of 780.58K.
It is up +0.38% in the last 24 hours and down -10.63% over the past month.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.
See More
Previous Close:
$93.98
Open:
$93.89
24h Volume:
780.58K
Relative Volume:
0.65
Market Cap:
$11.76B
Revenue:
-
Net Income/Loss:
$-507.65M
P/E Ratio:
-24.34
EPS:
-3.876
Net Cash Flow:
$-616.24M
1W Performance:
+6.55%
1M Performance:
-10.63%
6M Performance:
+38.90%
1Y Performance:
+89.78%
1-Day Range:
$91.97
$94.38
1-Week Range:
$89.06
$94.38
52-Week Range:
$50.04
$121.06
Vaxcyte Inc Stock (PCVX) Company Profile
Name
Vaxcyte Inc
Sector
Industry
Phone
650-837-0111
Address
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
Compare PCVX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PCVX
Vaxcyte Inc
|
94.34 | 11.76B | 0 | -507.65M | -616.24M | -4.60 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.13 | 120.56B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
750.22 | 82.44B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
616.55 | 36.87B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
253.07 | 32.64B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
118.39 | 28.38B | 3.30B | -501.07M | 1.03B | -2.1146 |
Vaxcyte Inc Stock (PCVX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-07-23 | Initiated | Mizuho | Buy |
| Apr-18-23 | Initiated | TD Cowen | Outperform |
| Jan-03-23 | Reiterated | Needham | Buy |
| Dec-15-22 | Initiated | Guggenheim | Buy |
| Nov-17-22 | Initiated | BTIG Research | Buy |
| Dec-29-21 | Resumed | Jefferies | Buy |
| Jun-24-21 | Resumed | Jefferies | Buy |
| Jul-07-20 | Initiated | BofA Securities | Buy |
| Jul-07-20 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-07-20 | Initiated | Needham | Buy |
View All
Vaxcyte Inc Stock (PCVX) Latest News
Braidwell LP Has $34 Million Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Fred Alger Management LLC Reduces Stake in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Acuta Capital Partners LLC Has $15.47 Million Stake in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaccine maker doubles its space at Bay Area biotech mega-campus - San Francisco Chronicle
Vaxcyte (PCVX) Surged On Positive Phase 2 Data For Its Drug - MSN
Fmr LLC Sells 366,673 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Citigroup Inc. Buys 54,748 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Fast-growing vaccine developer doubles San Carlos headquarters - The Business Journals
Local Real Estate Company Signs Major Bay Area Life Science Campus Lease With Vaxcyte - Pasadena Now
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Bought by Charles Schwab Investment Management Inc. - MarketBeat
Natixis Advisors LLC Grows Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Learn to Evaluate (PCVX) using the Charts - Stock Traders Daily
Intech Investment Management LLC Takes $3.23 Million Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Westfield Capital Management Co. LP Sells 189,474 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Sold by Eagle Asset Management Inc. - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Acquires 26,096 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
B. Metzler seel. Sohn & Co. Holding AG Makes New Investment in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Alexandria Announces Long-Term Lease at San Carlos Mega Campus - MSN
Vaxcyte expands headquarters with new lease agreement By Investing.com - Investing.com Canada
Vaxcyte expands headquarters with new lease agreement - Investing.com India
Alexandria Real Estate Equities, Inc. Announces Long-Term 258,581 RSF Lease With Longstanding Tenant Vaxcyte, Inc. at the Alexandria Center for Life ScienceSan Carlos Mega Campus - The Malaysian Reserve
Vaxcyte Signs Extension, Expansion at Alexandria Campus in San Carlos - Connect CRE
Alexandria Real Estate Equities, Inc. Announces Long-Term 258,58 - GuruFocus.com
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Sold by Segall Bryant & Hamill LLC - MarketBeat
Principal Financial Group Inc. Buys 34,287 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Jennison Associates LLC Lowers Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
First Turn Management LLC Sells 48,296 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Victory Capital Management Inc. Has $29.14 Million Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Curi RMB Capital LLC Invests $903,000 in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Los Angeles Capital Management LLC Purchases New Stake in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte (NASDAQ:PCVX) Sees Large Volume IncreaseStill a Buy? - MarketBeat
RA Capital Management, L.P. Increases Stake in Vaxcyte Inc - GuruFocus.com
Janus Henderson Group PLC's Strategic Acquisition of Vaxcyte Inc Shares - GuruFocus.com
Long Term Trading Analysis for (PCVX) - Stock Traders Daily
Vaxcyte Enters Oversold Territory (PCVX) - Nasdaq
FMR LLC Adjusts Stake in Vaxcyte Inc - GuruFocus.com
Vaxcyte provides regulatory updates on VAX-31 programs - TipRanks
FDA advances Vaxcyte's pneumococcal vaccine VAX-31 By Investing.com - Investing.com Canada
FDA advances Vaxcyte's pneumococcal vaccine VAX-31 - Investing.com
Vaxcyte Provides Positive Regulatory Updates on VAX-31 Pediatric and Adult Programs - The Bakersfield Californian
Vaxcyte's VAX-31 Vaccine Secures FDA Breakthrough Status, Targets 95% Disease Coverage | PCVX Stock News - StockTitan
WCM Investment Management LLC Has $15.94 Million Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Lisanti Capital Growth LLC Purchases 13,175 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Cantor Fitzgerald Increases Earnings Estimates for Vaxcyte - MarketBeat
TimesSquare Capital Management LLC Buys New Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) CEO Sells $245,803.74 in Stock - MarketBeat
Vaxcyte CEO Grant Pickering sells $245,796 in company stock - Investing.com India
Vaxcyte CEO Grant Pickering sells $245,796 in company stock By Investing.com - Investing.com Australia
Vaxcyte Inc Stock (PCVX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.61%
1.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):